Can contrast-enhanced us with targeted microbubbles monitor the response to antiangiogenic therapies?

Radiology

Volumn 246, Issue 2, 2008, Pages 339-340

  Kruskal, Jonathan B ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; MONOCLONAL ANTIBODY; VASCULOTROPIN RECEPTOR 2; ANALGESIC AGENT; ANGIOGENESIS INHIBITOR; CONTRAST MEDIUM;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANTIANGIOGENIC THERAPY; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE MARKER; DRUG RECEPTOR BINDING; ENDOTHELIUM CELL; IN VIVO STUDY; MICROBUBBLE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT RESPONSE; TUMOR CELL; ULTRASOUND; ANIMAL; DRUG DELIVERY SYSTEM; ECHOGRAPHY; IMAGE ENHANCEMENT; METABOLISM; METHODOLOGY; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); NOTE; PROGNOSIS; VASCULARIZATION;

ANALGESICS; ANGIOGENESIS INHIBITORS; ANIMALS; CONTRAST MEDIA; DRUG DELIVERY SYSTEMS; IMAGE ENHANCEMENT; MICE; MICROBUBBLES; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; ULTRASONOGRAPHY; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 39549118691     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2462071720     Document Type: Short Survey

References (8)

1. Willmann JK, Paulmurugan R, Chen K, et al. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology 2008;246:508-518.
2. Feng D, Nagy JA, Brekken RA, et al. Ultrastructural localization of the vascular permeabilityfactor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors. J Histochem Cytochem 2000;48:545-556.
3. Ellegala DB, Leong-Poi H, Carpenter JE, et al. Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3. Circulation 2003;108:336-341.
4. Arap W, Pasqualini R, Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 1998;279:377-380.
5. Lindner JR. Microbubbles in medical imaging: current applications and future directions. Nat Rev Drug Discov 2004;3:527-532.
6. Korpanty G, Carbon JG, Fleming JB, Brekken RA. Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature. Clin Cancer Res 2007;13:323-330.
7. Hakimé A, Peddi H, Hines-Peralta AU, et al. CT perfusion for determination of pharmacologically mediated blood flow changes in an animal tumor model. Radiology 2007;243:712-719.
8. Barrett T, Brechbiel M, Bernardo M, Choyke PL. MRI of tumor angiogenesis. J Magn Reson Imaging 2007;26:235-249.